Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EIF5A |
| Upstream (Parents) |
|---|
| (<<) ELL3 → EIF5A |
| (<<) OR1F1 → EIF5A |
| (<<) CELA2B → EIF5A |
| (<<) NEO1 → EIF5A |
| (<<) NR2C1 → EIF5A |
| (<<) GATA3 → EIF5A |
| (<<) TCEA2 → EIF5A |
| (<<) MEGF6 → EIF5A |
| (<<) PDE4C → EIF5A |
| (<<) NTRK1 → EIF5A |
| (<<) IFNB1 → EIF5A |
| (<<) ID1 → EIF5A |
| Downstream (Children) |
|---|
| EIF5A → GAS2L1 (>>) |
| EIF5A → CELA2B (>>) |
| EIF5A → PDE4C (>>) |
| EIF5A → NTRK1 (>>) |
